Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06854952 · ClinicalTrials.gov registry record · Phase 2
A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
A Phase 2 study, sponsored by Terns.
- Completed
- Registry status
- Phase 2
- Development phase
- 167
- Enrollment target
NCT06854952 is a Phase 2 study that has completed, run by Terns. The registered enrollment target is 167 participants.
The verdict
NCT06854952, a Phase 2 study, has completed, sponsored by Terns.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 167 participants
- Enrollment target
Study Summary
This is a Phase 2a multicenter, randomized, double-blind, placebo-controlled clinical trial studying the efficacy, safety, and tolerability of orally administered TERN-601 in adults with overweight or obesity.
Interventions
- OTHER Matching Placebo
- DRUG TERN-601
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2025-03-07 |
| Est. Completion | 2025-09-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06854952
The ClinicalTrials.gov registry entry for NCT06854952 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Terns, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Matching Placebo is the first listed.
NCT06854952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06854952 about?
NCT06854952 is a clinical study titled "A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity". This is a Phase 2a multicenter, randomized, double-blind, placebo-controlled clinical trial studying the efficacy, safety, and tolerability of orally administered TERN-601 in adults with overweight or obesity.
What is the current status of trial NCT06854952?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 167 participants. The study started on 2025-03-07. Estimated completion is 2025-09-19.
What interventions are being tested in trial NCT06854952?
The interventions under investigation include: Matching Placebo (OTHER), TERN-601 (DRUG).
Who is sponsoring clinical trial NCT06854952?
This trial is sponsored by Terns, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.